6ORV

Non-peptide agonist (TT-OAD2) bound to the Glucagon-Like peptide-1 (GLP-1) Receptor

これはPDB形式変換不可エントリーです。

6ORV の概要

• エントリーDOI: 10.2210/pdb6orv/pdb
• EMDBエントリー: 20179
• 分子名称: Guanine nucleotide-binding protein G(s) subunit alpha isoforms short, Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-1, Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-2, ... (6 entities in total)
• 機能のキーワード: g-coupled protein receptor, gpcr, non-peptide angonist, membrane protein
• 由来する生物種: Homo sapiens (Human); 詳細
• タンパク質・核酸の鎖数: 5
• 化学式量合計: 164824.63

構造登録者

Belousoff, M.J.,Liang, Y.L.,Danev, R. (登録日: 2019-05-01, 公開日: 2020-01-08, 最終更新日: 2024-10-16)

主引用文献

Zhao, P.,Liang, Y.L.,Belousoff, M.J.,Deganutti, G.,Fletcher, M.M.,Willard, F.S.,Bell, M.G.,Christe, M.E.,Sloop, K.W.,Inoue, A.,Truong, T.T.,Clydesdale, L.,Furness, S.G.B.,Christopoulos, A.,Wang, M.W.,Miller, L.J.,Reynolds, C.A.,Danev, R.,Sexton, P.M.,Wootten, D.
Activation of the GLP-1 receptor by a non-peptidic agonist.
Nature, 577:432-436, 2020

PubMed Abstract: Class B G-protein-coupled receptors are major targets for the treatment of chronic diseases, including diabetes and obesity. Structures of active receptors reveal peptide agonists engage deep within the receptor core, leading to an outward movement of extracellular loop 3 and the tops of transmembrane helices 6 and 7, an inward movement of transmembrane helix 1, reorganization of extracellular loop 2 and outward movement of the intracellular side of transmembrane helix 6, resulting in G-protein interaction and activation. Here we solved the structure of a non-peptide agonist, TT-OAD2, bound to the glucagon-like peptide-1 (GLP-1) receptor. Our structure identified an unpredicted non-peptide agonist-binding pocket in which reorganization of extracellular loop 3 and transmembrane helices 6 and 7 manifests independently of direct ligand interaction within the deep transmembrane domain pocket. TT-OAD2 exhibits biased agonism, and kinetics of G-protein activation and signalling that are distinct from peptide agonists. Within the structure, TT-OAD2 protrudes beyond the receptor core to interact with the lipid or detergent, providing an explanation for the distinct activation kinetics that may contribute to the clinical efficacy of this compound series. This work alters our understanding of the events that drive the activation of class B receptors.

PubMed: 31915381
DOI: 10.1038/s41586-019-1902-z

実験手法

ELECTRON MICROSCOPY (3 Å)